https://neurozone.org/wiki/ 2026-04-15T03:51:38+00:00 https://neurozone.org/wiki/ https://neurozone.org/wiki/lib/exe/fetch.php?media=wiki:dokuwiki.svg text/html 2025-05-25T04:35:29+00:00 sflitman (sflitman@undisclosed.example.com) https://neurozone.org/wiki/doku.php?id=ad&rev=1748147729&do=diff Alzheimer's Disease and Mild Cognitive Impairment Current evidence suggests ~80% of patients with Mild Cognitive Impairment (MCI) will eventually develop Alzheimer's disease (AD). Many times a trial is stated to be for Early AD which really covers both MCI and mild stage of AD. These trials involve novel approaches and new trial designs with the hope of more rapidly finding new answers for these conditions.<!----> <p align=justify> If you or a loved one is interested in participating in one … text/html 2024-10-14T00:41:01+00:00 sflitman (sflitman@undisclosed.example.com) https://neurozone.org/wiki/doku.php?id=epilepsy&rev=1728866461&do=diff Epilepsy and Seizure Disorders <!-- We have no currently enrolling trials for this indication, but will update this page when a new trial becomes available. --> Condition(s) Type of Drug Phase Add-On Placebo Duration Open Label Extension Prolonged Seizures Oral Spray Alprazolam III Yes 50% 18 weeks 4 years Partial Seizures Potassium Blocker III <p align=justify> If you or a loved one is interested in participating in one of our trials, please contact us… text/html 2024-10-14T00:40:31+00:00 sflitman (sflitman@undisclosed.example.com) https://neurozone.org/wiki/doku.php?id=ccm&rev=1728866431&do=diff Cerebral Cavernous Malformation Cavernous malformations are lesions in the brain which can grow and bleed, causing harm to the brain as a stroke, and irritability leading to seizures and epilepsy. We have no currently enrolling trials for this indication, but will update this page when a new trial becomes available.<!-- ^ Type of Drug ^ Phase ^ Placebo ^ Duration ^ Open Label Extension ^ | Novel oral agent | II | 33% | 12 months | Up to 12 months | --> <p align=ju… text/html 2024-10-14T00:39:37+00:00 sflitman (sflitman@undisclosed.example.com) https://neurozone.org/wiki/doku.php?id=wiki:navigation&rev=1728866377&do=diff * Start Page * Alzheimer's Disease * Cavernous Malformation * Epilepsy * Migraine * Multiple Sclerosis * Neuropathy * Parkinson's Disease * Trigeminal Neuralgia * History text/html 2024-10-14T00:38:23+00:00 sflitman (sflitman@undisclosed.example.com) https://neurozone.org/wiki/doku.php?id=success&rev=1728866303&do=diff Our Proud History We are a clinical research site founded in 2001 by Stephen Flitman, MD, a board-certified neurologist who trained at the Barrow Neurological Institute (Phoenix, Arizona) and completed his fellowship in Cognitive Neuroscience at the prestigious National Institutes of Health (Bethesda, Maryland). He served as first Associate Director then Director of Cognitive Neurology Section at Barrow until 2001. text/html 2024-04-06T21:50:59+00:00 sflitman (sflitman@undisclosed.example.com) https://neurozone.org/wiki/doku.php?id=pd&rev=1712440259&do=diff Parkinson's Disease With the advent of major organizations like the Michael J. Fox Foundation, Parkinson's research has never been busier. Current trials have focused on new symptomatic therapies and new methods of early diagnosis. Condition(s) Type of Drug Phase Add-On <p align=justify> If you or a loved one is interested in participating in one of our trials, please contact us at (855) 829-8899 or use the form below. One of our skilled Clinical Research Coordinators will contact you … text/html 2024-04-06T21:50:14+00:00 sflitman (sflitman@undisclosed.example.com) https://neurozone.org/wiki/doku.php?id=ms&rev=1712440214&do=diff Multiple Sclerosis Multiple sclerosis is a common condition of young people and mature adults, affecting nearly a million Americans. The most common form is Relapsing-Remitting, but there are also Primary Progressive, Secondary Progressive, and Progressive-Relapsing subtypes. New trials are directed against the disease itself, hoping to slow progression, or against particular symptoms like spasticity (stiffness of muscles and limbs). <!-- New trials are coming, please watch this space. | R… text/html 2024-04-06T21:48:40+00:00 sflitman (sflitman@undisclosed.example.com) https://neurozone.org/wiki/doku.php?id=mig&rev=1712440120&do=diff Migraine Migraine is arguably the most common neurological condition, affecting up to 80% of adults at some time in their lives. We have no current trials enrolling for migraine, but new opportunities may be posted soon. <!-- ^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open-Label Extension ^ | Adult episodic migraine preventive | Oral Zavegepant | III | Yes | 50% | 24 weeks | --> Response Form <p align=justify> If you or a loved one is…